Find Research Projects

Search results

• A Phase I Study to Evaluate the Safety and Parmacokineti

  Weigel, B. J.

  Amgen Inc.

  11/29/07 → 12/30/15

  Project: Research project

• A phase I study to evaluate the effect of NKTR-102 for i

  Potter, D. A.

  NEKTAR THERAPEUTICS

  4/15/14 → 4/18/19

  Project: Research project

• A Phase I Study of Neihulizumab (AbGn-168H) in Patients

  Holtan, S. G.

  ABGENOMICS INTERNATIONAL INC

  3/1/18 → 3/1/23

  Project: Research project

• A Phase I Study of HCW9218, a Bifunctional TGF-? Antagonist/IL-15 Protein Complex, in Select Advanced Solid Tumors After Failing at Least Two Prior Therapies

  Geller, M. A.

  HCW BIOLOGICS, INC

  1/21/22 → 1/31/26

  Project: Research project

• A Phase I Study of GNKG168 Administered by Intravenous I

  Bachanova, V.

  SBI Biotech

  6/1/11 → 6/30/15

  Project: Research project

• A Phase I Study of De-immunized DI-Leu16-IL2 Immunocytok

  Bachanova, V.

  ALOPEXX ONCOLOGY LLC

  12/1/12 → 5/30/18

  Project: Research project

• A Phase I Study of BMS-986015, an Anti-KIR Monoclonal An

  Cooley, S. A.

  BRISTOL-MYERS SQUIBB PHARM RES

  11/1/12 → 10/31/18

  Project: Research project

• A Phase I Study of an IL-2 Expressing, Attentuated Salmo

  Greeno, E. W.

  BOTANIC OIL INNOVATIONS

  1/30/10 → 4/30/14

  Project: Research project

• A Phase I randomized, double-blind, placebo-controlled,

  Young, J. H.

  GlaxoSmithKline

  2/6/09 → 8/21/12

  Project: Research project

• A Phase I Platform Study of Rucaparib in Metastatic Castrate-resistant Prostate Cancer: Evaluation of Dose and Safety/tolerability of a Combination of Rucaparib with Androgen Receptor Inhibitors and/or Immunotherapy

  Rao, A.

  CLOVIS ONCOLOGY, INC.

  9/1/19 → 9/30/24

  Project: Research project

• A Phase I Open Label Study to Evaluate the Safety andTolerability of ISP-001 in Patients with MucopolysaccharidosisType I

  Orchard, P. J.

  IMMUSOFT CORPORATION

  12/9/21 → 1/1/26

  Project: Research project

• A Phase I Open Label Pilot Study to Obtain Tissue for Hi

  Joyce, L. D.

  THEREGEN, INC

  2/2/07 → 12/31/07

  Project: Research project

• A Phase II Trial of Induction Carboplatin & Docetaxel Fo

  Geller, M. A.

  AVENTIS PHARM PRODUCTS INC

  7/29/04 → 6/1/10

  Project: Research project

• A Phase II Trial of Chemotherapy plus Pembrolizumab in patients with advanced NSCLC previously treatedwith PD-1 or PD-L1 Inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029

  Fujioka, N.

  BIG TEN CANCER RESEARCH CONSORTIUM

  12/1/17 → 11/30/22

  Project: Research project

• A Phase II Trial of Bevacizumab in Combination with Firs

  Dudek, A. Z.

  Genentech Inc.

  5/18/07 → 1/20/11

  Project: Research project

• A Phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium

  Erickson, B. K.

  UNIV. OF OKLAHOMA HEALTH SCIENCES CENTER

  10/31/18 → 10/31/23

  Project: Research project

• A Phase II trial evaluating goal directed therapy includ

  Tart, K., Peterson, K., Hall, K. & Powell, L.

  AKC Canine Health Foundation

  7/1/12 → 6/30/15

  Project: Research project

• A Phase II Study Testing the Safety and Activity of AGS-

  Dudek, A. Z.

  Argos Therapeutics, Inc.

  5/2/08 → 5/31/13

  Project: Research project

• A Phase II Study of Treosulfan/Fludarabine/Low Dose Tota

  Verneris, M. R.

  National Marrow Donor Program

  4/1/13 → 3/31/16

  Project: Research project

• A Phase II Study of TAK-228 in patients with previously

  Ryan, C. & Gupta, S.

  Dana-Farber Cancer Institute

  9/1/17 → 9/30/22

  Project: Research project

• A Phase II Study of Sunitinib Malate Single Agent for th

  Haddad, T. & Yee, D.

  PFIZER, INC.

  7/1/07 → 10/31/10

  Project: Research project

• A Phase II Study of Radiation Therapy, Paclitaxel, Polig

  Kratzke, R. A.

  CELL THERAPEUTICS INC

  12/4/06 → 2/1/10

  Project: Research project

• A Phase II Study of Pzaopanib in the Treatment of Surgic

  Skubitz, K.

  ACORN RESEARCH, LLC

  7/21/12 → 7/30/16

  Project: Research project

• A phase II study of oral Panobinostat in adult patients

  Bachanova, V.

  NOVARTIS PHARMACEUTICALS CORPORATION

  6/15/08 → 1/30/11

  Project: Research project

• A Phase II Study of Milataxel (TL139) Administered Orall

  Kumar, P.

  TAXOLOG, INC.

  4/1/08 → 4/30/10

  Project: Research project

• a Phase II Study of Lapatinib plus Topotecan or Lapatini

  Yee, D.

  GlaxoSmithKline

  1/12/07 → 9/15/09

  Project: Research project

• A Phase II Study of Lapatinib for Brain Metastases in Su

  Yee, D.

  GlaxoSmithKline

  11/22/05 → 11/1/09

  Project: Research project

• A Phase II Study of HyperAcute-Pancreatic Cancer Vaccine

  Greeno, E. W.

  NEW LINK GENETICS

  6/13/08 → 6/30/18

  Project: Research project

• A Phase II Study of Fulvestrant (Faslodex) in the Treatm

  Argenta, P. A.

  AstraZeneca

  12/1/06 → 12/31/09

  Project: Research project

• A Phase II Study of FOLFOX combined with Nab-Paclitaxel (FOLFOX-A) in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma

  Lou, E.

  BIG TEN CANCER RESEARCH CONSORTIUM

  12/1/17 → 11/30/22

  Project: Research project

• A Phase II Single Arm Trial of BIBW 2992 in non small ce

  Dudek, A. Z.

  Boehringer-Ingelheim Pharmaceuticals

  3/27/07 → 6/30/13

  Project: Research project

• A Phase II Single-Arm Study of Therapeutic Iobenguane (131I) For Relapsed, High-Risk Neuroblastoma Subjects (OPTIMUM Trial)PROTOCOL MIBG 2014-01

  Greengard, E. G.

  JUBILANT DRAXLMAGE INC

  2/1/19 → 2/28/24

  Project: Research project

• A Phase II Randomized Trial of Docetaxel Based Induction

  Kumar, P., Ondrey, F. G. & Gaffney, P.

  ROSALIND FRANKLIN UNIV OF MED & SCI

  11/3/04 → 6/30/14

  Project: Research project

• A Phase II randomized, double-blind, placebo controlled

  Cheng, E. Y.

  Novartis Pharma AG

  11/1/11 → 4/30/19

  Project: Research project

• A phase II pilot trial to estimate survival after a non-total body irradiation (TBI) based conditioning regimen in patients diagnosed with B-acute lymphoblastic leukemia (ALL) who are pre-allogeneic hematopoietic cell transplantation (HCT) next-generatio

  MacMillan, M. L. & Neglia, J. P.

  CHILDREN'S HOSPITAL LOS ANGELES

  2/1/20 → 1/31/25

  Project: Research project

• A Phase II Multi-Center, Randomized, Double-Blind, Plac

  Judson, P.

  Insert Therapeutics, Inc.

  9/30/08 → 4/23/09

  Project: Research project

• A Phase II Multicenter, Randomized, Double-Blind, 12-Week Treatment, 3-Arm, Parallel-Group, Placebo-Controlled Study to Investigate the Efficacy, Safety and Tolerability of RO7017773 in Participants Aged 15to 45 Years with Autism Spectrum Disorder (ASD

  Jacob, S.

  HOFFMANN-LA ROCHE PHARMACEUTICALS

  8/14/20 → 8/30/25

  Project: Research project

• A Phase II Multicenter, Open-Label Study of YM155 in Ref

  Bachanova, V.

  Astellas Pharma US, Inc.

  2/8/07 → 5/31/10

  Project: Research project

• A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10%(Human) with Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion(Human), 10% (GAMMAGARD LIQUID/KIOVIG)

  Allen, J. A.

  Baxalta US Inc.

  11/14/19 → 5/31/22

  Project: Research project

• A Phase III Study on the Safety, Pharmacokinetics and Ef

  Reding, M. T.

  REVO BIOLOGICS, INC.

  6/1/14 → 5/31/18

  Project: Research project

• A phase III study of STI 571 vs interferon-a (IFN-a) com

  Peterson, B. A.

  NOVARTIS PHARMACEUTICALS CORPORATION

  7/20/00 → 7/31/12

  Project: Research project

• A Phase III Study of 131I Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for ChildrenWith Newly Diagnosed High-Risk Neuroblastoma (NBL)

  Greengard, E. G.

  Public Health Institute

  1/1/22 → 12/31/22

  Project: Research project

• A Phase III Study of 131I Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added t Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)

  Greengard, E. G.

  Children's Hospital of Philadelphia

  1/1/19 → 12/31/21

  Project: Research project

• A Phase III study comparing single-agent olaparib or the

  Geller, M. A.

  NRG ONCOLOGY FOUNDATION, INC.

  10/1/16 → 2/28/25

  Project: Research project

• A Phase III Randomized Trial for Patients with de novo

  Neglia, J. P. & Weigel, B. J.

  Children's Hospital of Philadelphia

  1/30/13 → 10/1/17

  Project: Research project

• A Phase III Randomized Trial Comparing Androgen Deprivat

  Ryan, C. & Gupta, S.

  Brigham and Women’s Hospital

  7/30/15 → 12/31/27

  Project: Research project

• A Phase III Randomized Study of Neuroadiab in Combinatio

  Trusheim, J. E.

  Bradmer Pharmaceuticals, Inc.

  5/30/08 → 8/31/09

  Project: Research project

• A Phase III Randomized Study of BAY 43-9006 in Patients

  Dudek, A. Z.

  BAYER CORP

  5/26/04 → 5/25/09

  Project: Research project

• A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for theTreatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects

  Young, J. H.

  ANSUN BIOPHARMA, INC.

  2/6/19 → 2/29/24

  Project: Research project

• A Phase III Randomized Double-Blind, Placebo-Controlled

  Dunitz, J. M.

  Altus Pharmaceuticals Inc.

  5/2/07 → 10/30/08

  Project: Research project